SCHEMBL4108372

SCHEMBL4108372

Cc1cccc(NC(=O)C2CNCCN2c2nc(N)nc3ccc(-c4ccccc4Cl)nc23)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
POLB P06746 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HCRTR1 O43613 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
PI4KB Q9UBF8 1/20 0.38
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.36
USP2 O75604 1/20 0.36
TSHR P16473 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
LIMK2 P53671 1/20 0.35
MAPK1 P28482 1/20 0.35
GAA P10253 1/20 0.35
CCKBR P32239 1/20 0.35
PDE4A P27815 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4121021 0.91 ALDH1A1 (0.38) ALDH1A1POLBPI4KBMAPTUSP2
SCHEMBL4708335 0.89 MAPT (0.44) ALDH1A1POLBMEN1KMT2ACYP1A2
SCHEMBL4121381 0.89 MAPT (0.38) ALDH1A1POLBMEN1KMT2ACYP1A2
SCHEMBL4116800 0.88 PI4KB (0.40) ALDH1A1POLBPI4KBMAPTUSP2
SCHEMBL3922088 0.88 ALDH1A1 (0.40) ALDH1A1POLBPI4KBMAPTUSP2
SCHEMBL4118504 0.86 PI4KB (0.39) ALDH1A1POLBMEN1KMT2ACYP1A2
SCHEMBL4108734 0.85 PI4KB (0.38) ALDH1A1POLBPI4KBMAPTUSP2
SCHEMBL4107810 0.85 POLB (0.39) ALDH1A1POLBMEN1KMT2API4KB
SCHEMBL4108347 0.84 MKNK1 (0.38) ALDH1A1POLBPI4KBMAPTUSP2
SCHEMBL4102550 0.84 POLB (0.38) ALDH1A1POLBPI4KBMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090264415-A2 PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR MEDICAL TREATMENT 4 AZA IP NV (BE) 2009-10-22 US disclosed
US-20090036430-A1 PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR MEDICAL TREATMENT 4 AZA IP NV (BE) 2009-02-05 US disclosed
US-20080004285-A1 PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR MEDICAL TREATMENT 4 AZA IP NV (BE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004285-A1 PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR MEDICAL TREATMENT PNPO, TYMP, PNP ALDH1A1 1225/4885POLB 283/4885MEN1 3783/4885
US-20090036430-A1 PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR MEDICAL TREATMENT PNPO, TYMP, PNP ALDH1A1 1225/4885POLB 283/4885MEN1 3783/4885
US-20090264415-A2 PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR MEDICAL TREATMENT PNPO, TYMP, PNP ALDH1A1 1225/4885POLB 283/4885MEN1 3783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.